CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Trade Payables History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Trade Payables | ₹3,230 Cr | ₹2,837 Cr | ₹2,474 Cr | ₹2,535 Cr | ₹2,508 Cr |
What is the latest Trade Payables ratio of CIPLA ?
| Year | Trade Payables |
|---|---|
| Mar2026 | ₹3,230 Cr |
| Mar2025 | ₹2,837 Cr |
| Mar2024 | ₹2,474 Cr |
| Mar2023 | ₹2,535 Cr |
| Mar2022 | ₹2,508 Cr |
How is Trade Payables of CIPLA Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,230 Cr | 13.83 | |
| Mar2025 | ₹2,837 Cr | 14.69 | |
| Mar2024 | ₹2,474 Cr | -2.39 | |
| Mar2023 | ₹2,535 Cr | 1.05 | |
| Mar2022 | ₹2,508 Cr | - | |
Compare Trade Payables of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹117,320.8 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
| MANKIND PHARMA | ₹104,550.0 Cr | 1.7% | 8.3% | 9.4% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.3% |
3.7% |
-2.3% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses